Skip to Main Content

Paper Details

Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer.
J Urol
2
2022
Author NameAffiliation
Rosina T LisNational Cancer Institute
Stephanie A HarmonNational Cancer Institute
Baris TurkbeyNational Cancer Institute
Adam G SowalskyNational Cancer Institute
  • 1 - 4

Datasets

Release 1.2